Home » Newsletters » BioWorld

BioWorld

July 8, 1993

View Archived Issues

IMMUNE RESPONSE REGISTERS SHARES

XYTRONYX RAISES $1.74 MILLION

TRIPLEX COLLABORATES WITH WISTAR RESEARCHER

VESTAR STARTS TRIALS

INTERLEUKIN SAVES MICE

OXFORD COMPLETES FUND-RAISING

GENICA READIES CMT DIAGNOSTIC

TRIALS OF DENTAL COMPOUND APPROVED

OPPOSITION FORMS AGAINST MEDICAID FORMULARIES

EPA REGISTERS ECOGEN BIOPESTICIDE

COLLABORATIVE SELLS TESTING BUSINESS

AGOURON HALTS TRIALS ON DRUG FOR PSORIASIS

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...